Literature DB >> 11439360

Histological grading of oral epithelial dysplasia: revisited.

S Warnakulasuriya1.   

Abstract

Treatment of oral precancer is largely based on histological grading of epithelial dysplasia, despite the fact that this estimation is subjective and therefore carries a low reproducibility. The grade of epithelial dysplasia may not be proportional to the risk of malignant potential and clinical characteristics may complement therapeutic decisions. Molecular genetic changes found in oral epithelial dysplasia remain unclear and at present lack clinical significance. Genomic and proliferation markers are likely to be associated with histopathological parameters, but their relationship with the grading of dysplasia remains uncertain. They are potential biomarker candidates but their utility in prognosis of oral precancer deserves further study. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11439360     DOI: 10.1002/1096-9896(200107)194:3<294::AID-PATH911>3.0.CO;2-Q

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  26 in total

1.  Demographic and Clinicopathologic Features of Actinic Cheilitis and Lip Squamous Cell Carcinoma: a Brazilian Multicentre Study.

Authors:  Leni Verônica de Oliveira Silva; José Alcides Almeida de Arruda; Lucas Guimarães Abreu; Raquel Conceição Ferreira; Leorik Pereira da Silva; Cibele Pelissari; Ricardo Natã Fonseca Silva; Kaio Heide Sampaio Nóbrega; Bruno Augusto Benevenuto de Andrade; Mario José Romañach; Michelle Agostini; Cassiano Francisco Weege Nonaka; Pollianna Muniz Alves; Hélder Antônio Rebelo Pontes; Luís Fernando Rivero; Lélia Batista de Souza; Marília Trierveiler; Elismauro Francisco Mendonça; Ana Paula Neutzling Gomes; Manoela Domingues Martins; Emanuel Sávio de Souza Andrade; Marcia Maria Fonseca da Silveira; Ana Paula Veras Sobral; Ricardo Alves Mesquita
Journal:  Head Neck Pathol       Date:  2020-02-19

2.  Double reporting and second opinion in head and neck pathology.

Authors:  Julia A Woolgar; Asterios Triantafyllou; Lester D R Thompson; Jennifer L Hunt; James S Lewis; Michelle D Williams; Antonio Cardesa; Alessandra Rinaldo; Leon Barnes; Pieter J Slootweg; Kenneth O Devaney; Douglas R Gnepp; William H Westra; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-01-17       Impact factor: 2.503

Review 3.  Oral premalignant lesions: from the pathological viewpoint.

Authors:  Toshiyuki Izumo
Journal:  Int J Clin Oncol       Date:  2011-01-14       Impact factor: 3.402

Review 4.  Novel management of oral cancer: a paradigm of predictive oncology.

Authors:  Jon Sudbø
Journal:  Clin Med Res       Date:  2004-11

5.  Oral leukoplakia - an update.

Authors:  Ioanina Parlatescu; Carmen Gheorghe; Elena Coculescu; Serban Tovaru
Journal:  Maedica (Buchar)       Date:  2014-03

6.  Impact of Age on Disease Progression and Microenvironment in Oral Cancer.

Authors:  V K Vincent-Chong; H DeJong; L J Rich; A Patti; M Merzianu; P A Hershberger; M Seshadri
Journal:  J Dent Res       Date:  2018-05-11       Impact factor: 6.116

7.  Current challenges and the diagnostic pitfalls in the grading of epithelial dysplasia in oral potentially malignant disorders: A review.

Authors:  Sonia Gupta; Manveen Kaur Jawanda; G S Madhushankari
Journal:  J Oral Biol Craniofac Res       Date:  2020-09-19

8.  A study of actinic cheilitis treatment by two low-morbidity CO2 laser vaporization one-pass protocols.

Authors:  Flávio Francisco de Godoy Peres; Adriana Aigotti Haberbeck Brandão; Yasmin Rodarte Carvalho; Ulysses Dória Filho; Hélio Plapler
Journal:  Lasers Med Sci       Date:  2008-06-14       Impact factor: 3.161

9.  Reproducibility of grading systems in oral epithelial dysplasia.

Authors:  Adesh Manchanda; Devi-Charan Shetty
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-11-01

10.  Oral squamous cell carcinoma in relation to field precancerisation: pathobiology.

Authors:  Liviu L Feller; Razia Rag Khammissa; Beverly B Kramer; Johan J Lemmer
Journal:  Cancer Cell Int       Date:  2013-04-03       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.